Introduktion
Den här sidan ger en omfattande analys av den kända insiderhandelshistoriken för Frank J Williams. Insiders är tjänstemän, styrelseledamöter eller betydande investerare i ett företag. Det är olagligt för insiders att göra affärer i sina företag baserat på specifik, icke-offentlig information. Detta betyder inte att det är olagligt för dem att göra några affärer i sina egna företag. De måste dock rapportera alla affärer till SEC via ett formulär 4. Trots dessa restriktioner tyder akademisk forskning på att insiders – i allmänhet – tenderar att överträffa marknaden i sina egna företag.
Genomsnittlig handelslönsamhet
Den genomsnittliga handelslönsamheten är den genomsnittliga avkastningen av alla köp på den öppna marknaden som insidern gjort under de senaste tre åren. För att beräkna detta undersöker vi alla oplanerade köp på öppen marknad som görs av insidern, exklusive alla affärer som markerats som en del av en 10b5-1-handelsplan. Vi beräknar sedan den genomsnittliga prestandan för dessa affärer under 3, 6 och 12 månader, med ett genomsnitt av var och en av dessa varaktigheter för att generera ett slutgiltigt resultatmått för varje affär. Slutligen tar vi ett genomsnitt av alla prestationsmått för att beräkna ett prestationsmått för insidern. Denna lista inkluderar endast insiders som har gjort minst tre affärer under de senaste två åren.
Om lönsamheten för denna insiderhandel är "N/A", så har insidern antingen inte gjort några köp på den öppna marknaden under de senaste tre åren, eller så är affärerna de har gjort för nya för att kunna beräkna ett tillförlitligt resultatmått.
Uppdateringsfrekvens: Dagligen
Företag med rapporterade insiderpositioner
SEC-anmälningarna visar att Frank J Williams har rapporterat innehav eller affärer i följande företag:
Värdepapper | Titel | Senaste rapporterade innehav |
---|---|---|
US:EVH / Evolent Health, Inc. | Director | 819 812 |
US:ABCO / Advisory Board Co. (The) | Director | 14 701 |
Hur man tolkar diagrammen
Följande diagram visar aktieutvecklingen för värdepapper efter varje icke-planerad handel på öppen marknad som görs av Frank J Williams. Icke-planerad handel är affärer som inte gjordes som en del av en 10b5-1-handelsplan. Aktieutvecklingen visas som kumulativ procentuell förändring av aktiekursen. Till exempel, om en insiderhandel gjordes den 1 januari 2019, kommer diagrammet att visa den dagliga procentuella förändringen av värdepapperet fram till idag. Om aktiekursen skulle gå från $10 till $15 under denna tid, skulle den kumulativa procentuella förändringen i aktiekursen vara 50%. En förändring i priset från 10 USD till 20 USD skulle vara 100 % och en prisändring på 10 USD till 5 USD skulle vara -50 %.
I slutändan försöker vi avgöra hur nära insiders affärer korrelerar med överavkastning (positiv eller negativ) i aktiekursen för att se om insidern tar tid för sina affärer att dra nytta av insiderinformation. Tänk på situationen där en insider gjorde detta. I den här situationen förväntar vi oss antingen (a) positiv avkastning efter köp eller (b) negativ avkastning efter försäljning. I fallet med (a) skulle KÖP-diagrammet visa en serie uppåtlutande kurvor, vilket indikerar positiv avkastning efter varje köptransaktion. I fallet med (b) skulle SALE-diagrammet visa en serie nedåtlutande kurvor, vilket indikerar negativ avkastning efter varje försäljningstransaktion.
Detta är dock inte tillräckligt för att dra slutsatser. Om till exempel aktiekursen i bolaget var i en icke-cyklisk stigning under många år, skulle vi förvänta oss att alla tomter efter köpet skulle vara uppåtlutande. Likaså skulle icke-cykliska nedgångar under många år resultera i nedåtlutande post-trade tomter. Inget av dessa diagram skulle tyda på insiderhandel.
Den starkaste indikatorn skulle vara en situation där aktiekursen var extremt cyklisk, och det fanns både positiva signaler i KÖP-diagrammet och negativa plotter på SALE-diagrammet. Denna situation skulle i hög grad tyda på en insider som tog tid för affärer till sin ekonomiska fördel.
Insiderköp EVH / Evolent Health, Inc. - Analys av kortsiktig vinst
I det här avsnittet analyserar vi lönsamheten för varje oplanerat insiderköp på en öppen marknad som görs i EVH / Evolent Health, Inc.. Denna analys hjälper till att förstå om insidern konsekvent genererar onormal avkastning och är värd att följa. Denna analys är för ett år efter varje handel, och resultaten är teoretiska .
Tabellen nedan visar de senaste öppna marknadsköpen som inte var en del av en automatisk handelsplan.
Handelsdatum | Ticker | Insider | Rapporterade aktier |
Rapporterad pris |
Justerade aktier |
Justerat pris |
Kostnadsgrund | Dagar till max |
Pris vid max |
Max vinst ($) |
Maximal avkastning (%) |
---|---|---|---|---|---|---|---|---|---|---|---|
2019-12-03 | EVH | WILLIAMS FRANK J | 35 000 | 6,5100 | 35 000 | 6,5100 | 227 850 | 360 | 15.1900 | 303 800 | 133,33 |
Det justerade prisetär det justerade priset efter split. Justerade aktier er de split-justerade aktier.
Insiderförsäljning - Analys av kortsiktig förlust
I det här avsnittet analyserar vi det kortsiktiga undvikandet av förluster för varje oplanerad insiderförsäljning på öppen marknad som görs i EVH / Evolent Health, Inc.. Ett konsekvent mönster för att undvika förluster kan tyda på att framtida försäljningstransaktioner kan förutsäga prisnedgångar. Denna analys är för ett år efter varje handel, och resultaten är teoretiska .
Följande tabell visar de senaste försäljningarna på den öppna marknaden som inte ingick i en automatisk handelsplan.
Det justerade prisetär det justerade priset efter split. Justerade aktier er de split-justerade aktier.
Insiderhandelshistorik
Den här tabellen visar den fullständiga listan över insideraffärer gjorda av Frank J Williams som avslöjats för Securities Exchange Commission (SEC).
Fildatum | Transaktionsdatum | Schema | Ticker | Värdepapper | Kode | Aktier | Återstående aktier | Procentuell förandring | Aktie pris |
Transaktionsvärde | Återstående värde |
|
---|---|---|---|---|---|---|---|---|---|---|---|---|
2023-06-05 |
|
4 | EVH |
Evolent Health, Inc.
Class A Common Stock |
S - Sale | X | −49 026 | 819 812 | −5,64 | 29,74 | −1 458 033 | 24 381 209 |
2023-06-05 |
|
4 | EVH |
Evolent Health, Inc.
Class A Common Stock |
S - Sale | X | −41 914 | 868 838 | −4,60 | 29,26 | −1 226 404 | 25 422 200 |
2023-06-05 |
|
4 | EVH |
Evolent Health, Inc.
Class A Common Stock |
S - Sale | X | −9 969 | 910 752 | −1,08 | 29,75 | −296 578 | 27 094 872 |
2023-06-05 |
|
4 | EVH |
Evolent Health, Inc.
Class A Common Stock |
S - Sale | X | −9 091 | 920 721 | −0,98 | 29,27 | −266 094 | 26 949 504 |
2023-06-05 |
|
4 | EVH |
Evolent Health, Inc.
Class A Common Stock |
M - Exercise | X | 90 940 | 929 812 | 10,84 | 10,27 | 933 954 | 9 549 169 |
2023-06-05 |
|
4 | EVH |
Evolent Health, Inc.
Class A Common Stock |
M - Exercise | X | 19 060 | 838 872 | 2,32 | 6,87 | 130 942 | 5 763 051 |
2023-05-03 |
|
4 | EVH |
Evolent Health, Inc.
Class A Common Stock |
S - Sale | X | −110 000 | 819 812 | −11,83 | 36,29 | −3 991 900 | 29 750 977 |
2023-05-03 |
|
4 | EVH |
Evolent Health, Inc.
Class A Common Stock |
M - Exercise | X | 110 000 | 929 812 | 13,42 | 6,87 | 755 700 | 6 387 808 |
2023-04-05 |
|
4 | EVH |
Evolent Health, Inc.
Class A Common Stock |
S - Sale | X | −5 874 | 819 812 | −0,71 | 32,37 | −190 141 | 26 537 314 |
2023-04-05 |
|
4 | EVH |
Evolent Health, Inc.
Class A Common Stock |
S - Sale | X | −104 126 | 825 686 | −11,20 | 31,80 | −3 311 207 | 26 256 815 |
2023-04-05 |
|
4 | EVH |
Evolent Health, Inc.
Class A Common Stock |
M - Exercise | X | 110 000 | 929 812 | 13,42 | 6,87 | 755 700 | 6 387 808 |
2023-03-07 |
|
4 | EVH |
Evolent Health, Inc.
Class A Common Stock |
S - Sale | X | −116 311 | 819 812 | −12,42 | 34,62 | −4 026 687 | 28 381 891 |
2023-03-07 |
|
4 | EVH |
Evolent Health, Inc.
Class A Common Stock |
S - Sale | X | −2 455 | 936 123 | −0,26 | 35,01 | −85 950 | 32 773 666 |
2023-03-07 |
|
4 | EVH |
Evolent Health, Inc.
Class A Common Stock |
S - Sale | X | −87 901 | 938 578 | −8,56 | 34,40 | −3 023 794 | 32 287 083 |
2023-03-07 |
|
4 | EVH |
Evolent Health, Inc.
Class A Common Stock |
M - Exercise | 400 000 | 1 026 479 | 63,85 | ||||
2023-03-02 |
|
4 | EVH |
Evolent Health, Inc.
Class A Common Stock |
S - Sale | X | −100 940 | 626 479 | −13,88 | 34,98 | −3 530 881 | 21 914 235 |
2023-03-02 |
|
4 | EVH |
Evolent Health, Inc.
Class A Common Stock |
M - Exercise | X | 100 940 | 727 419 | 16,11 | 6,87 | 693 458 | 4 997 369 |
2023-03-02 |
|
4 | EVH |
Evolent Health, Inc.
Class A Common Stock |
S - Sale | X | −9 060 | 626 479 | −1,43 | 34,97 | −316 828 | 21 907 971 |
2023-03-02 |
|
4 | EVH |
Evolent Health, Inc.
Class A Common Stock |
M - Exercise | X | 9 060 | 635 539 | 1,45 | 3,84 | 34 790 | 2 440 470 |
2023-02-03 |
|
4 | EVH |
Evolent Health, Inc.
Class A Common Stock |
S - Sale | X | −1 500 | 626 479 | −0,24 | 32,66 | −48 990 | 20 460 804 |
2023-02-03 |
|
4 | EVH |
Evolent Health, Inc.
Class A Common Stock |
S - Sale | X | −108 500 | 627 979 | −14,73 | 32,15 | −3 488 275 | 20 189 525 |
2023-02-03 |
|
4 | EVH |
Evolent Health, Inc.
Class A Common Stock |
M - Exercise | X | 110 000 | 736 479 | 17,56 | 3,84 | 422 400 | 2 828 079 |
2023-01-05 |
|
4 | EVH |
Evolent Health, Inc.
Class A Common Stock |
S - Sale | X | −3 292 | 626 479 | −0,52 | 28,18 | −92 769 | 17 654 178 |
2023-01-05 |
|
4 | EVH |
Evolent Health, Inc.
Class A Common Stock |
S - Sale | X | −106 708 | 629 771 | −14,49 | 27,12 | −2 893 921 | 17 079 390 |
2023-01-05 |
|
4 | EVH |
Evolent Health, Inc.
Class A Common Stock |
M - Exercise | X | 110 000 | 736 479 | 17,56 | 3,84 | 422 400 | 2 828 079 |
2022-12-05 |
|
4 | EVH |
Evolent Health, Inc.
Class A Common Stock |
S - Sale | X | −900 | 626 479 | −0,14 | 29,09 | −26 181 | 18 224 274 |
2022-12-05 |
|
4 | EVH |
Evolent Health, Inc.
Class A Common Stock |
S - Sale | X | −109 100 | 627 379 | −14,81 | 28,29 | −3 086 439 | 17 748 552 |
2022-12-05 |
|
4 | EVH |
Evolent Health, Inc.
Class A Common Stock |
M - Exercise | X | 110 000 | 736 479 | 17,56 | 3,84 | 422 400 | 2 828 079 |
2022-11-03 |
|
4 | EVH |
Evolent Health, Inc.
Class A Common Stock |
S - Sale | X | −677 | 626 479 | −0,11 | 31,81 | −21 535 | 19 928 297 |
2022-11-03 |
|
4 | EVH |
Evolent Health, Inc.
Class A Common Stock |
S - Sale | X | −13 773 | 627 156 | −2,15 | 30,26 | −416 771 | 18 977 741 |
2022-11-03 |
|
4 | EVH |
Evolent Health, Inc.
Class A Common Stock |
S - Sale | X | −57 438 | 640 929 | −8,22 | 29,36 | −1 686 380 | 18 817 675 |
2022-11-03 |
|
4 | EVH |
Evolent Health, Inc.
Class A Common Stock |
S - Sale | X | −38 112 | 698 367 | −5,17 | 28,88 | −1 100 675 | 20 168 839 |
2022-11-03 |
|
4 | EVH |
Evolent Health, Inc.
Class A Common Stock |
M - Exercise | X | 110 000 | 736 479 | 17,56 | 3,84 | 422 400 | 2 828 079 |
2022-08-25 |
|
4 | EVH |
Evolent Health, Inc.
Class A Common Stock |
S - Sale | −50 000 | 752 434 | −6,23 | 37,21 | −1 860 500 | 27 998 069 | |
2022-08-25 |
|
4 | EVH |
Evolent Health, Inc.
Class A Common Stock |
M - Exercise | 50 000 | 802 434 | 6,65 | 13,95 | 697 500 | 11 193 954 | |
2022-08-25 |
|
4 | EVH |
Evolent Health, Inc.
Class A Common Stock |
S - Sale | −150 000 | 752 434 | −16,62 | 35,75 | −5 362 500 | 26 899 516 | |
2022-08-25 |
|
4 | EVH |
Evolent Health, Inc.
Class A Common Stock |
M - Exercise | 150 000 | 902 434 | 19,94 | 3,84 | 576 000 | 3 465 347 | |
2022-06-13 |
|
4 | EVH |
Evolent Health, Inc.
Class A Common Stock |
F - Taxes | −3 860 | 752 434 | −0,51 | 28,76 | −111 014 | 21 640 002 | |
2022-06-13 |
|
4 | EVH |
Evolent Health, Inc.
Class A Common Stock |
A - Award | 5 564 | 756 434 | 0,74 | ||||
2022-03-10 |
|
4 | EVH |
Evolent Health, Inc.
Class A Common Stock |
F - Taxes | −189 568 | 750 730 | −20,16 | 27,54 | −5 220 703 | 20 675 104 | |
2022-03-10 |
|
4 | EVH |
Evolent Health, Inc.
Leveraged Restricted Stock Unit |
M - Exercise | −382 489 | 0 | −100,00 | ||||
2022-03-10 |
|
4 | EVH |
Evolent Health, Inc.
Class A Common Stock |
M - Exercise | 382 489 | 940 298 | 68,57 | ||||
2022-02-18 |
|
4 | EVH |
Evolent Health, Inc.
Class A Common Stock Option (right to buy) |
M - Exercise | X | −10 000 | 599 060 | −1,64 | |||
2022-02-18 |
|
4 | EVH |
Evolent Health, Inc.
Class A Common Stock |
S - Sale | X | −10 000 | 557 809 | −1,76 | 23,70 | −237 000 | 13 220 073 |
2022-02-18 |
|
4 | EVH |
Evolent Health, Inc.
Class A Common Stock |
S - Sale | X | −10 000 | 557 809 | −1,76 | 23,70 | −237 000 | 13 220 073 |
2022-02-18 |
|
4 | EVH |
Evolent Health, Inc.
Class A Common Stock |
M - Exercise | X | 10 000 | 577 809 | 1,76 | 3,84 | 38 400 | 2 218 787 |
2022-02-14 |
|
5 | EVH |
Evolent Health, Inc.
Class A Common Stock |
G - Gift | 66 064 | 66 064 | |||||
2022-02-14 |
|
5 | EVH |
Evolent Health, Inc.
Class A Common Stock |
G - Gift | −66 064 | 0 | −100,00 | ||||
2022-01-20 |
|
4 | EVH |
Evolent Health, Inc.
Class A Common Stock Option (right to buy) |
M - Exercise | X | −10 000 | 609 060 | −1,62 | |||
2022-01-20 |
|
4 | EVH |
Evolent Health, Inc.
Class A Common Stock |
S - Sale | X | −10 000 | 567 809 | −1,73 | 24,30 | −243 000 | 13 797 759 |
2022-01-20 |
|
4 | EVH |
Evolent Health, Inc.
Class A Common Stock |
S - Sale | X | −10 000 | 577 809 | −1,70 | 24,31 | −243 100 | 14 046 537 |
2022-01-20 |
|
4 | EVH |
Evolent Health, Inc.
Class A Common Stock |
M - Exercise | X | 10 000 | 587 809 | 1,73 | 3,84 | 38 400 | 2 257 187 |
2021-12-17 |
|
4 | EVH |
Evolent Health, Inc.
Class A Common Stock Option (right to buy) |
M - Exercise | X | −10 000 | 619 060 | −1,59 | |||
2021-12-17 |
|
4 | EVH |
Evolent Health, Inc.
Class A Common Stock |
S - Sale | X | −10 000 | 577 809 | −1,70 | 26,65 | −266 500 | 15 398 610 |
2021-12-17 |
|
4 | EVH |
Evolent Health, Inc.
Class A Common Stock |
S - Sale | X | −10 000 | 587 809 | −1,67 | 26,64 | −266 400 | 15 659 232 |
2021-12-17 |
|
4 | EVH |
Evolent Health, Inc.
Class A Common Stock |
M - Exercise | X | 10 000 | 597 809 | 1,70 | 3,84 | 38 400 | 2 295 587 |
2021-11-18 |
|
4 | EVH |
Evolent Health, Inc.
Class A Common Stock Option (right to buy) |
M - Exercise | X | −10 000 | 629 060 | −1,56 | |||
2021-11-18 |
|
4 | EVH |
Evolent Health, Inc.
Class A Common Stock |
S - Sale | X | −10 000 | 587 809 | −1,67 | 27,81 | −278 100 | 16 346 968 |
2021-11-18 |
|
4 | EVH |
Evolent Health, Inc.
Class A Common Stock |
S - Sale | X | −10 000 | 587 809 | −1,67 | 27,81 | −278 100 | 16 346 968 |
2021-11-18 |
|
4 | EVH |
Evolent Health, Inc.
Class A Common Stock |
M - Exercise | X | 10 000 | 607 809 | 1,67 | 3,84 | 38 400 | 2 333 987 |
2021-10-20 |
|
4 | EVH |
Evolent Health, Inc.
Class A Common Stock Option (right to buy) |
M - Exercise | X | −10 000 | 639 060 | −1,54 | |||
2021-10-20 |
|
4 | EVH |
Evolent Health, Inc.
Class A Common Stock |
S - Sale | X | −10 000 | 597 809 | −1,65 | 30,35 | −303 500 | 18 143 503 |
2021-10-20 |
|
4 | EVH |
Evolent Health, Inc.
Class A Common Stock |
S - Sale | X | −10 000 | 597 809 | −1,65 | 30,35 | −303 500 | 18 143 503 |
2021-10-20 |
|
4 | EVH |
Evolent Health, Inc.
Class A Common Stock |
M - Exercise | X | 10 000 | 617 809 | 1,65 | 3,84 | 38 400 | 2 372 387 |
2021-09-20 |
|
4 | EVH |
Evolent Health, Inc.
Class A Common Stock Option (right to buy) |
M - Exercise | X | −10 000 | 649 060 | −1,52 | |||
2021-09-20 |
|
4 | EVH |
Evolent Health, Inc.
Class A Common Stock |
S - Sale | X | −10 000 | 607 809 | −1,62 | 26,27 | −262 700 | 15 967 142 |
2021-09-20 |
|
4 | EVH |
Evolent Health, Inc.
Class A Common Stock |
S - Sale | X | −10 000 | 607 809 | −1,62 | 26,27 | −262 700 | 15 967 142 |
2021-09-20 |
|
4 | EVH |
Evolent Health, Inc.
Class A Common Stock |
M - Exercise | X | 10 000 | 627 809 | 1,62 | 3,84 | 38 400 | 2 410 787 |
2021-08-19 |
|
4 | EVH |
Evolent Health, Inc.
Class A Common Stock Option (right to buy) |
M - Exercise | X | −10 000 | 659 060 | −1,49 | |||
2021-08-19 |
|
4 | EVH |
Evolent Health, Inc.
Class A Common Stock |
S - Sale | X | −10 000 | 617 809 | −1,59 | 22,88 | −228 800 | 14 135 470 |
2021-08-19 |
|
4 | EVH |
Evolent Health, Inc.
Class A Common Stock |
S - Sale | X | −10 000 | 617 809 | −1,59 | 22,88 | −228 800 | 14 135 470 |
2021-08-19 |
|
4 | EVH |
Evolent Health, Inc.
Class A Common Stock |
M - Exercise | X | 10 000 | 637 809 | 1,59 | 3,84 | 38 400 | 2 449 187 |
2021-08-04 |
|
4 | EVH |
Evolent Health, Inc.
Class A Common Stock Option (right to buy) |
M - Exercise | X | −25 871 | 669 060 | −3,72 | |||
2021-08-04 |
|
4 | EVH |
Evolent Health, Inc.
Class A Common Stock |
S - Sale | X | −25 919 | 627 809 | −3,96 | 23,02 | −596 655 | 14 452 163 |
2021-08-04 |
|
4 | EVH |
Evolent Health, Inc.
Class A Common Stock |
S - Sale | X | −25 871 | 653 728 | −3,81 | 23,02 | −595 550 | 15 048 819 |
2021-08-04 |
|
4 | EVH |
Evolent Health, Inc.
Class A Common Stock |
M - Exercise | X | 25 871 | 679 599 | 3,96 | 3,84 | 99 345 | 2 609 660 |
2021-08-04 |
|
4 | EVH |
Evolent Health, Inc.
Class A Common Stock Option (right to buy) |
M - Exercise | X | −6 144 | 694 931 | −0,88 | |||
2021-08-04 |
|
4 | EVH |
Evolent Health, Inc.
Class A Common Stock |
S - Sale | X | −6 165 | 653 728 | −0,93 | 23,02 | −141 918 | 15 048 819 |
2021-08-04 |
|
4 | EVH |
Evolent Health, Inc.
Class A Common Stock |
S - Sale | X | −6 144 | 659 893 | −0,92 | 23,02 | −141 435 | 15 190 737 |
2021-08-04 |
|
4 | EVH |
Evolent Health, Inc.
Class A Common Stock |
M - Exercise | X | 6 144 | 666 037 | 0,93 | 3,84 | 23 593 | 2 557 582 |
2021-08-03 |
|
4 | EVH |
Evolent Health, Inc.
Class A Common Stock Option (right to buy) |
M - Exercise | X | −1 901 | 701 075 | −0,27 | |||
2021-08-03 |
|
4 | EVH |
Evolent Health, Inc.
Class A Common Stock |
S - Sale | X | −1 601 | 659 893 | −0,24 | 23,00 | −36 823 | 15 177 539 |
2021-08-03 |
|
4 | EVH |
Evolent Health, Inc.
Class A Common Stock |
S - Sale | X | −1 901 | 661 494 | −0,29 | 23,00 | −43 723 | 15 214 362 |
2021-08-03 |
|
4 | EVH |
Evolent Health, Inc.
Class A Common Stock |
M - Exercise | X | 1 901 | 663 395 | 0,29 | 3,84 | 7 300 | 2 547 437 |
2021-07-21 |
|
4 | EVH |
Evolent Health, Inc.
Class A Common Stock Option (right to buy) |
M - Exercise | X | −10 000 | 702 976 | −1,40 | |||
2021-07-21 |
|
4 | EVH |
Evolent Health, Inc.
Class A Common Stock |
S - Sale | X | −10 000 | 661 494 | −1,49 | 21,60 | −216 000 | 14 288 270 |
2021-07-21 |
|
4 | EVH |
Evolent Health, Inc.
Class A Common Stock |
S - Sale | X | −10 000 | 661 494 | −1,49 | 21,60 | −216 000 | 14 288 270 |
2021-07-21 |
|
4 | EVH |
Evolent Health, Inc.
Class A Common Stock |
M - Exercise | X | 10 000 | 681 494 | 1,49 | 3,84 | 38 400 | 2 616 937 |
2021-07-13 |
|
4 | EVH |
Evolent Health, Inc.
Class A Common Stock Option (right to buy) |
M - Exercise | X | −3 584 | 712 976 | −0,50 | |||
2021-07-13 |
|
4 | EVH |
Evolent Health, Inc.
Class A Common Stock |
S - Sale | X | −3 584 | 671 494 | −0,53 | 23,00 | −82 432 | 15 444 362 |
2021-07-13 |
|
4 | EVH |
Evolent Health, Inc.
Class A Common Stock |
S - Sale | X | −3 584 | 671 494 | −0,53 | 23,00 | −82 432 | 15 444 362 |
2021-07-13 |
|
4 | EVH |
Evolent Health, Inc.
Class A Common Stock |
M - Exercise | X | 3 584 | 675 078 | 0,53 | 3,84 | 13 763 | 2 592 300 |
2021-06-21 |
|
4 | EVH |
Evolent Health, Inc.
Class A Common Stock Option (right to buy) |
M - Exercise | X | −10 000 | 716 560 | −1,38 | |||
2021-06-21 |
|
4 | EVH |
Evolent Health, Inc.
Class A Common Stock |
S - Sale | X | −10 000 | 648 294 | −1,52 | 19,70 | −197 000 | 12 771 392 |
2021-06-21 |
|
4 | EVH |
Evolent Health, Inc.
Class A Common Stock |
S - Sale | X | −10 000 | 648 294 | −1,52 | 19,70 | −197 000 | 12 771 392 |
2021-06-21 |
|
4 | EVH |
Evolent Health, Inc.
Class A Common Stock |
M - Exercise | X | 10 000 | 658 294 | 1,54 | 3,84 | 38 400 | 2 527 849 |
2021-06-14 |
|
4 | EVH |
Evolent Health, Inc.
Class A Common Stock |
A - Award | 7 785 | 658 294 | 1,20 | ||||
2021-05-19 |
|
4 | EVH |
Evolent Health, Inc.
Class A Common Stock Option (right to buy) |
M - Exercise | X | −10 000 | 726 560 | −1,36 | |||
2021-05-19 |
|
4 | EVH |
Evolent Health, Inc.
Class A Common Stock |
S - Sale | X | −10 000 | 650 509 | −1,51 | 19,65 | −196 500 | 12 782 502 |
2021-05-19 |
|
4 | EVH |
Evolent Health, Inc.
Class A Common Stock |
S - Sale | X | −10 000 | 660 509 | −1,49 | 19,81 | −198 100 | 13 084 683 |
2021-05-19 |
|
4 | EVH |
Evolent Health, Inc.
Class A Common Stock |
M - Exercise | X | 10 000 | 670 509 | 1,51 | 3,84 | 38 400 | 2 574 755 |
2020-03-04 |
|
4 | EVH |
Evolent Health, Inc.
Leveraged Restricted Stock Unit |
A - Award | 200 000 | 400 000 | 100,00 | ||||
2019-12-05 |
|
4 | EVH |
Evolent Health, Inc.
Class A Common Stock |
P - Purchase | 35 000 | 623 655 | 5,95 | 6,51 | 227 850 | 4 059 994 | |
2019-03-05 |
|
4 | EVH |
Evolent Health, Inc.
Leveraged Restricted Stock Unit |
A - Award | 249 000 | 249 000 | |||||
2018-08-22 |
|
4 | EVH |
Evolent Health, Inc.
Class A Common Stock |
S - Sale | X | −3 878 | 718 357 | −0,54 | 24,00 | −93 072 | 17 240 568 |
2018-08-20 |
|
4 | EVH |
Evolent Health, Inc.
Class A Common Stock |
S - Sale | X | −7 956 | 722 235 | −1,09 | 24,00 | −190 944 | 17 333 640 |
2018-08-20 |
|
4 | EVH |
Evolent Health, Inc.
Class A Common Stock |
S - Sale | X | −29 953 | 730 191 | −3,94 | 24,02 | −719 471 | 17 539 188 |
2018-08-16 |
|
4 | EVH |
Evolent Health, Inc.
Class A Common Stock |
S - Sale | X | −5 545 | 760 144 | −0,72 | 24,00 | −133 080 | 18 243 456 |
2018-08-16 |
|
4 | EVH |
Evolent Health, Inc.
Class A Common Stock |
S - Sale | X | −35 470 | 765 689 | −4,43 | 24,02 | −851 989 | 18 391 850 |
2018-08-03 |
|
4 | EVH |
Evolent Health, Inc.
Class A Common Stock |
S - Sale | X | −9 653 | 801 159 | −1,19 | 19,97 | −192 770 | 15 999 145 |
2018-07-05 |
|
4 | EVH |
Evolent Health, Inc.
Class A Common Stock |
S - Sale | X | −10 231 | 810 812 | −1,25 | 21,22 | −217 102 | 17 205 431 |
2018-06-25 |
|
4 | EVH |
Evolent Health, Inc.
Class A Common Stock |
S - Sale | X | −47 314 | 821 043 | −5,45 | 24,00 | −1 135 536 | 19 705 032 |
2018-06-05 |
|
4 | EVH |
Evolent Health, Inc.
Class A Common Stock |
S - Sale | X | −15 000 | 868 357 | −1,70 | 20,04 | −300 600 | 17 401 874 |
2018-05-16 |
|
4 | EVH |
Evolent Health, Inc.
Class A Common Stock |
S - Sale | X | −15 000 | 883 357 | −1,67 | 19,02 | −285 300 | 16 801 450 |
2018-02-05 |
|
4 | EVH |
Evolent Health, Inc.
Class A Common Stock Option (right to buy) |
A - Award | 227 273 | 227 273 | |||||
2018-02-05 |
|
4 | EVH |
Evolent Health, Inc.
Class A Common Stock |
A - Award | 96 774 | 898 357 | 12,07 | ||||
2017-08-04 |
|
4 | EVH |
Evolent Health, Inc.
Class A Common Stock |
S - Sale | X | −16 300 | 801 583 | −1,99 | 23,73 | −386 799 | 19 021 565 |
2017-07-10 |
|
4 | EVH |
Evolent Health, Inc.
Class A Common Stock |
S - Sale | X | −1 250 | 817 883 | −0,15 | 25,27 | −31 588 | 20 667 903 |
2017-07-10 |
|
4 | EVH |
Evolent Health, Inc.
Class A Common Stock |
S - Sale | X | −15 050 | 819 133 | −1,80 | 24,72 | −372 036 | 20 248 968 |
2017-06-05 |
|
4 | EVH |
Evolent Health, Inc.
Class A Common Stock |
S - Sale | X | −11 800 | 834 183 | −1,39 | 24,36 | −287 448 | 20 320 698 |
2017-06-05 |
|
4 | EVH |
Evolent Health, Inc.
Class A Common Stock |
S - Sale | X | −4 500 | 845 983 | −0,53 | 23,49 | −105 705 | 19 872 141 |
2017-05-23 |
|
4 | EVH |
Evolent Health, Inc.
Class A Common Stock |
S - Sale | −114 865 | 850 483 | −11,90 | 24,30 | −2 791 220 | 20 666 737 | |
2017-05-08 |
|
4 | EVH |
Evolent Health, Inc.
Class A Common Stock |
S - Sale | X | −16 300 | 1 284 943 | −1,25 | 23,55 | −383 865 | 30 260 408 |
2017-04-10 |
|
4 | EVH |
Evolent Health, Inc.
Class A Common Stock |
S - Sale | X | −16 300 | 1 301 243 | −1,24 | 22,03 | −359 089 | 28 666 383 |
2017-03-06 |
|
4 | EVH |
Evolent Health, Inc.
Class A Common Stock |
S - Sale | X | −16 300 | 1 317 543 | −1,22 | 20,86 | −340 018 | 27 483 947 |
2017-02-17 |
|
4 | EVH |
Evolent Health, Inc.
Class A Common Stock |
S - Sale | X | −16 300 | 1 333 843 | −1,21 | 20,13 | −328 119 | 26 850 260 |
2017-02-17 |
|
4 | EVH |
Evolent Health, Inc.
Class A Common Stock |
S - Sale | X | −16 300 | 1 350 143 | −1,19 | 20,16 | −328 608 | 27 218 883 |
2017-02-03 |
|
4 | EVH |
Evolent Health, Inc.
Class A Common Stock Option (right to buy) |
A - Award | 137 868 | 137 868 | |||||
2017-02-03 |
|
4 | EVH |
Evolent Health, Inc.
Class A Common Stock |
A - Award | 61 644 | 1 366 443 | 4,72 | ||||
2016-09-15 |
|
4 | EVH |
Evolent Health, Inc.
Class A Common Stock |
S - Sale | −251 481 | 1 304 799 | −16,16 | 21,54 | −5 416 901 | 28 105 370 | |
2016-03-03 |
|
4 | EVH |
Evolent Health, Inc.
Class A Common Stock Option (right to buy) |
A - Award | 54 095 | 1 347 035 | 4,18 | ||||
2016-03-03 |
|
4 | EVH |
Evolent Health, Inc.
Class A Common Stock Option (right to buy) |
A - Award | 54 095 | 1 347 035 | 4,18 | ||||
2016-03-03 |
|
4 | EVH |
Evolent Health, Inc.
Class A Common Stock Option (right to buy) |
A - Award | 54 095 | 1 347 035 | 4,18 | ||||
2016-03-03 |
|
4 | EVH |
Evolent Health, Inc.
Class A Common Stock Option (right to buy) |
A - Award | 108 190 | 1 347 035 | 8,73 | ||||
2016-03-03 |
|
4 | EVH |
Evolent Health, Inc.
Class A Common Stock |
A - Award | 48 685 | 1 236 685 | 4,10 | ||||
2015-06-05 |
|
4 | ABCO |
ADVISORY BOARD CO
Common Stock |
M - Exercise | 2 104 | 14 701 | 16,70 | ||||
2015-06-05 | 3 | EVH |
Evolent Health, Inc.
Class A Common Stock |
2 376 000 | ||||||||
2015-06-05 | 3 | EVH |
Evolent Health, Inc.
Class A Common Stock |
2 376 000 | ||||||||
2015-05-13 |
|
4 | ABCO |
ADVISORY BOARD CO
Common Stock |
M - Exercise | 2 592 | 12 597 | 25,91 | ||||
2015-04-14 |
|
4 | ABCO |
ADVISORY BOARD CO
Restricted Stock Units |
A - Award | 2 104 | 2 104 | |||||
2015-01-15 |
|
4 | ABCO |
ADVISORY BOARD CO
Common Stock |
J - Other | −10 004 | 10 005 | −50,00 | ||||
2014-05-20 |
|
4 | ABCO |
ADVISORY BOARD CO
Common Stock |
M - Exercise | 3 968 | 20 009 | 24,74 | ||||
2014-04-29 |
|
4 | ABCO |
ADVISORY BOARD CO
Common Stock |
M - Exercise | 6 500 | 16 041 | 68,13 | ||||
2014-04-17 |
|
4 | ABCO |
ADVISORY BOARD CO
Common Stock |
M - Exercise | 2 162 | 9 541 | 29,30 | ||||
2014-04-15 |
|
4 | ABCO |
ADVISORY BOARD CO
Restricted Stock Units |
A - Award | 2 592 | 2 592 | |||||
2014-03-26 |
|
4 | ABCO |
ADVISORY BOARD CO
Common Stock |
S - Sale | X | −717 | 7 379 | −8,86 | 66,63 | −47 774 | 491 663 |
2014-03-26 |
|
4 | ABCO |
ADVISORY BOARD CO
Common Stock |
S - Sale | X | −2 283 | 8 096 | −22,00 | 65,89 | −150 427 | 533 445 |
2014-03-12 |
|
4 | ABCO |
ADVISORY BOARD CO
Common Stock |
S - Sale | X | −3 000 | 10 379 | −22,42 | 67,75 | −203 250 | 703 177 |
2014-02-27 |
|
4 | ABCO |
ADVISORY BOARD CO
Common Stock |
S - Sale | X | −3 000 | 13 379 | −18,32 | 63,98 | −191 940 | 855 988 |
2014-02-13 |
|
4 | ABCO |
ADVISORY BOARD CO
Common Stock |
S - Sale | X | −2 717 | 16 379 | −14,23 | 59,08 | −160 520 | 967 671 |
2014-02-13 |
|
4 | ABCO |
ADVISORY BOARD CO
Common Stock |
S - Sale | X | −283 | 19 096 | −1,46 | 58,62 | −16 589 | 1 119 408 |
2014-01-30 |
|
4 | ABCO |
ADVISORY BOARD CO
Common Stock |
S - Sale | X | −3 000 | 19 379 | −13,41 | 63,21 | −189 630 | 1 224 947 |
2014-01-16 |
|
4 | ABCO |
ADVISORY BOARD CO
Common Stock |
S - Sale | X | −100 | 22 379 | −0,44 | 60,02 | −6 002 | 1 343 188 |
2014-01-16 |
|
4 | ABCO |
ADVISORY BOARD CO
Common Stock |
S - Sale | X | −2 900 | 22 479 | −11,43 | 59,57 | −172 753 | 1 339 074 |
2013-09-03 |
|
4 | ABCO |
ADVISORY BOARD CO
Common Stock |
S - Sale | X | −1 000 | 25 379 | −3,79 | 56,13 | −56 130 | 1 424 523 |
2013-09-03 |
|
4 | ABCO |
ADVISORY BOARD CO
Common Stock |
S - Sale | X | −6 000 | 26 379 | −18,53 | 55,13 | −330 780 | 1 454 274 |
2013-09-03 |
|
4 | ABCO |
ADVISORY BOARD CO
Common Stock |
M - Exercise | X | 7 000 | 32 379 | 27,58 | 17,14 | 119 980 | 554 976 |
2013-08-26 |
|
4 | ABCO |
ADVISORY BOARD CO
Common Stock Options |
M - Exercise | X | −10 000 | 7 000 | −58,82 | |||
2013-08-26 |
|
4 | ABCO |
ADVISORY BOARD CO
Common Stock |
S - Sale | X | −10 000 | 25 379 | −28,27 | 56,22 | −562 200 | 1 426 807 |
2013-08-26 |
|
4 | ABCO |
ADVISORY BOARD CO
Common Stock |
M - Exercise | X | 10 000 | 35 379 | 39,40 | 17,14 | 171 400 | 606 396 |
2013-08-19 |
|
4 | ABCO |
ADVISORY BOARD CO
Common Stock Options |
M - Exercise | X | −10 000 | 17 000 | −37,04 | |||
2013-08-19 |
|
4 | ABCO |
ADVISORY BOARD CO
Common Stock |
S - Sale | X | −10 000 | 25 379 | −28,27 | 55,99 | −559 900 | 1 420 970 |
2013-08-19 |
|
4 | ABCO |
ADVISORY BOARD CO
Common Stock |
M - Exercise | X | 10 000 | 35 379 | 39,40 | 17,14 | 171 400 | 606 396 |
2013-08-13 |
|
4 | ABCO |
ADVISORY BOARD CO
Common Stock Options |
M - Exercise | X | −10 000 | 27 000 | −27,03 | |||
2013-08-13 |
|
4 | ABCO |
ADVISORY BOARD CO
Common Stock |
S - Sale | X | −100 | 25 379 | −0,39 | 58,40 | −5 840 | 1 482 134 |
2013-08-13 |
|
4 | ABCO |
ADVISORY BOARD CO
Common Stock |
S - Sale | X | −9 900 | 25 479 | −27,98 | 57,85 | −572 715 | 1 473 960 |
2013-08-13 |
|
4 | ABCO |
ADVISORY BOARD CO
Common Stock |
M - Exercise | X | 10 000 | 35 379 | 39,40 | 17,14 | 171 400 | 606 396 |
2013-08-06 |
|
4 | ABCO |
ADVISORY BOARD CO
Common Stock Options |
M - Exercise | X | −10 000 | 37 000 | −21,28 | |||
2013-08-06 |
|
4 | ABCO |
ADVISORY BOARD CO
Common Stock |
S - Sale | X | −1 400 | 25 379 | −5,23 | 58,51 | −81 914 | 1 484 925 |
2013-08-06 |
|
4 | ABCO |
ADVISORY BOARD CO
Common Stock |
S - Sale | X | −8 600 | 26 779 | −24,31 | 58,14 | −500 004 | 1 556 931 |
2013-08-06 |
|
4 | ABCO |
ADVISORY BOARD CO
Common Stock |
M - Exercise | X | 10 000 | 35 379 | 39,40 | 17,14 | 171 400 | 606 396 |
2013-07-30 |
|
4 | ABCO |
ADVISORY BOARD CO
Common Stock Options |
M - Exercise | X | −10 000 | 47 000 | −17,54 | |||
2013-07-30 |
|
4 | ABCO |
ADVISORY BOARD CO
Common Stock |
S - Sale | X | −10 000 | 25 379 | −28,27 | 56,71 | −567 100 | 1 439 243 |
2013-07-30 |
|
4 | ABCO |
ADVISORY BOARD CO
Common Stock |
M - Exercise | X | 10 000 | 35 379 | 39,40 | 17,14 | 171 400 | 606 396 |
2013-07-16 |
|
4 | ABCO |
ADVISORY BOARD CO
Common Stock Options |
M - Exercise | X | −10 000 | 57 000 | −14,93 | |||
2013-07-16 |
|
4 | ABCO |
ADVISORY BOARD CO
Common Stock |
S - Sale | X | −600 | 25 379 | −2,31 | 57,26 | −34 356 | 1 453 202 |
2013-07-16 |
|
4 | ABCO |
ADVISORY BOARD CO
Common Stock |
S - Sale | X | −9 400 | 25 979 | −26,57 | 56,63 | −532 322 | 1 471 191 |
2013-07-16 |
|
4 | ABCO |
ADVISORY BOARD CO
Common Stock |
M - Exercise | X | 10 000 | 35 379 | 39,40 | 17,14 | 171 400 | 606 396 |
2013-07-09 |
|
4 | ABCO |
ADVISORY BOARD CO
Common Stock Options |
M - Exercise | X | −10 000 | 67 000 | −12,99 | |||
2013-07-09 |
|
4 | ABCO |
ADVISORY BOARD CO
Common Stock |
S - Sale | X | −100 | 25 379 | −0,39 | 55,78 | −5 578 | 1 415 641 |
2013-07-09 |
|
4 | ABCO |
ADVISORY BOARD CO
Common Stock |
S - Sale | X | −9 900 | 25 479 | −27,98 | 54,60 | −540 540 | 1 391 153 |
2013-07-09 |
|
4 | ABCO |
ADVISORY BOARD CO
Common Stock |
M - Exercise | X | 10 000 | 35 379 | 39,40 | 17,14 | 171 400 | 606 396 |
2013-06-25 |
|
4 | ABCO |
ADVISORY BOARD CO
Common Stock Options |
M - Exercise | X | −10 000 | 77 000 | −11,49 | |||
2013-06-25 |
|
4 | ABCO |
ADVISORY BOARD CO
Common Stock |
S - Sale | X | −10 000 | 25 379 | −28,27 | 53,42 | −534 200 | 1 355 746 |
2013-06-25 |
|
4 | ABCO |
ADVISORY BOARD CO
Common Stock |
M - Exercise | X | 10 000 | 35 379 | 39,40 | 17,14 | 171 400 | 606 396 |
2013-06-18 |
|
4 | ABCO |
ADVISORY BOARD CO
Common Stock Options |
M - Exercise | X | −3 000 | 87 000 | −3,33 | |||
2013-06-18 |
|
4 | ABCO |
ADVISORY BOARD CO
Common Stock Options |
M - Exercise | X | −7 000 | 13 000 | −35,00 | |||
2013-06-18 |
|
4 | ABCO |
ADVISORY BOARD CO
Common Stock |
S - Sale | X | −800 | 25 379 | −3,06 | 53,23 | −42 584 | 1 350 924 |
2013-06-18 |
|
4 | ABCO |
ADVISORY BOARD CO
Common Stock |
S - Sale | X | −9 200 | 26 179 | −26,00 | 52,46 | −482 632 | 1 373 350 |
2013-06-18 |
|
4 | ABCO |
ADVISORY BOARD CO
Common Stock |
M - Exercise | X | 3 000 | 35 379 | 9,27 | 17,14 | 51 420 | 606 396 |
2013-06-18 |
|
4 | ABCO |
ADVISORY BOARD CO
Common Stock |
M - Exercise | X | 7 000 | 32 379 | 27,58 | 16,58 | 116 060 | 536 844 |
2013-06-11 |
|
4 | ABCO |
ADVISORY BOARD CO
Common Stock Options |
M - Exercise | X | −4 728 | 9 458 | −33,33 | |||
2013-06-11 |
|
4 | ABCO |
ADVISORY BOARD CO
Common Stock Options |
M - Exercise | X | −6 000 | 20 000 | −23,08 | |||
2013-06-11 |
|
4 | ABCO |
ADVISORY BOARD CO
Common Stock |
S - Sale | X | −600 | 25 379 | −2,31 | 52,51 | −31 506 | 1 332 651 |
2013-06-11 |
|
4 | ABCO |
ADVISORY BOARD CO
Common Stock |
S - Sale | X | −10 128 | 25 979 | −28,05 | 51,75 | −524 124 | 1 344 413 |
2013-06-11 |
|
4 | ABCO |
ADVISORY BOARD CO
Common Stock |
M - Exercise | X | 4 728 | 36 107 | 15,07 | 24,23 | 114 559 | 874 873 |
2013-06-11 |
|
4 | ABCO |
ADVISORY BOARD CO
Common Stock |
M - Exercise | X | 6 000 | 31 379 | 23,64 | 16,58 | 99 480 | 520 264 |
2013-05-21 |
|
4 | ABCO |
ADVISORY BOARD CO
Common Stock |
M - Exercise | 4 336 | 25 379 | 20,61 | ||||
2013-05-01 |
|
4 | ABCO |
ADVISORY BOARD CO
Restricted Stock Units |
M - Exercise | −6 500 | 6 500 | −50,00 | ||||
2013-05-01 |
|
4 | ABCO |
ADVISORY BOARD CO
Common Stock |
M - Exercise | 6 500 | 21 043 | 44,70 | ||||
2013-04-22 |
|
4 | ABCO |
ADVISORY BOARD CO
Restricted Stock Units |
A - Award | 3 968 | 3 968 | |||||
2013-04-17 |
|
4 | ABCO |
ADVISORY BOARD CO
Restricted Stock Units |
M - Exercise | −2 162 | 2 162 | −50,00 | ||||
2013-04-17 |
|
4 | ABCO |
ADVISORY BOARD CO
Common Stock |
M - Exercise | 2 162 | 14 543 | 17,46 | ||||
2012-12-12 |
|
4 | ABCO |
ADVISORY BOARD CO
Common Stock |
G - Gift | −10 341 | 12 381 | −45,51 | ||||
2012-12-12 |
|
4 | ABCO |
ADVISORY BOARD CO
Common Stock Options |
M - Exercise | X | −4 730 | 14 186 | −25,01 | |||
2012-12-12 |
|
4 | ABCO |
ADVISORY BOARD CO
Common Stock |
S - Sale | X | −10 301 | 22 722 | −31,19 | 48,45 | −499 083 | 1 100 881 |
2012-12-12 |
|
4 | ABCO |
ADVISORY BOARD CO
Common Stock |
M - Exercise | X | 4 730 | 33 023 | 16,72 | 24,23 | 114 608 | 800 147 |
2012-12-12 |
|
4 | ABCO |
ADVISORY BOARD CO
Common Stock |
M - Exercise | X | 5 571 | 28 293 | 24,52 | 16,58 | 92 367 | 469 098 |
2012-11-28 |
|
4 | ABCO |
ADVISORY BOARD CO
Common Stock Options |
M - Exercise | X | −10 301 | 5 571 | −64,90 | |||
2012-11-28 |
|
4 | ABCO |
ADVISORY BOARD CO
Common Stock |
S - Sale | X | −10 301 | 22 722 | −31,19 | 43,30 | −446 033 | 983 863 |
2012-11-28 |
|
4 | ABCO |
ADVISORY BOARD CO
Common Stock |
M - Exercise | X | 10 301 | 33 023 | 45,33 | 16,58 | 170 791 | 547 521 |
2012-11-14 |
|
4 | ABCO |
ADVISORY BOARD CO
Common Stock Options |
M - Exercise | X | −10 128 | 15 872 | −38,95 | |||
2012-11-14 |
|
4 | ABCO |
ADVISORY BOARD CO
Common Stock |
S - Sale | X | −3 789 | 22 722 | −14,29 | 45,85 | −173 726 | 1 041 804 |
2012-11-14 |
|
4 | ABCO |
ADVISORY BOARD CO
Common Stock |
S - Sale | X | −6 512 | 26 511 | −19,72 | 45,41 | −295 710 | 1 203 865 |
2012-11-14 |
|
4 | ABCO |
ADVISORY BOARD CO
Common Stock |
M - Exercise | X | 173 | 33 023 | 0,53 | 17,41 | 3 012 | 574 930 |
2012-11-14 |
|
4 | ABCO |
ADVISORY BOARD CO
Common Stock |
M - Exercise | X | 10 128 | 32 850 | 44,57 | 16,58 | 167 922 | 544 653 |
2012-11-02 |
|
4 | ABCO |
ADVISORY BOARD CO
Common Stock Options |
M - Exercise | X | −5 571 | 173 | −96,99 | |||
2012-11-02 |
|
4 | ABCO |
ADVISORY BOARD CO
Common Stock |
S - Sale | X | −3 000 | 22 722 | −11,66 | 47,32 | −141 960 | 1 075 205 |
2012-11-02 |
|
4 | ABCO |
ADVISORY BOARD CO
Common Stock |
S - Sale | X | −6 000 | 25 722 | −18,91 | 46,48 | −278 880 | 1 195 559 |
2012-11-02 |
|
4 | ABCO |
ADVISORY BOARD CO
Common Stock |
S - Sale | X | −1 301 | 31 722 | −3,94 | 45,86 | −59 664 | 1 454 771 |
2012-11-02 |
|
4 | ABCO |
ADVISORY BOARD CO
Common Stock |
M - Exercise | X | 10 301 | 33 023 | 45,33 | 17,41 | 179 340 | 574 930 |
2012-10-17 |
|
4 | ABCO |
ADVISORY BOARD CO
Common Stock Options |
M - Exercise | X | −10 301 | 4 730 | −68,53 | |||
2012-10-17 |
|
4 | ABCO |
ADVISORY BOARD CO
Common Stock |
S - Sale | X | −10 301 | 22 722 | −31,19 | 47,93 | −493 727 | 1 089 065 |
2012-10-17 |
|
4 | ABCO |
ADVISORY BOARD CO
Common Stock |
M - Exercise | X | 10 301 | 33 023 | 45,33 | 17,41 | 179 340 | 574 930 |
2012-10-03 |
|
4 | ABCO |
ADVISORY BOARD CO
Common Stock Options |
M - Exercise | X | −10 301 | 15 031 | −40,66 | |||
2012-10-03 |
|
4 | ABCO |
ADVISORY BOARD CO
Common Stock |
S - Sale | X | −10 301 | 22 722 | −31,19 | 47,74 | −491 770 | 1 084 748 |
2012-10-03 |
|
4 | ABCO |
ADVISORY BOARD CO
Common Stock |
M - Exercise | X | 10 301 | 33 023 | 45,33 | 17,41 | 179 340 | 574 930 |
2012-09-19 |
|
4 | ABCO |
ADVISORY BOARD CO
Common Stock Options |
M - Exercise | X | −10 304 | 25 332 | −28,91 | |||
2012-09-19 |
|
4 | ABCO |
ADVISORY BOARD CO
Common Stock |
S - Sale | X | −10 304 | 22 722 | −31,20 | 46,17 | −475 736 | 1 049 075 |
2012-09-19 |
|
4 | ABCO |
ADVISORY BOARD CO
Common Stock |
M - Exercise | X | 10 304 | 33 026 | 45,35 | 17,41 | 179 393 | 574 983 |
2012-08-29 |
|
4 | ABCO |
ADVISORY BOARD CO
Common Stock Options |
M - Exercise | X | −5 200 | 35 636 | −12,73 | |||
2012-08-29 |
|
4 | ABCO |
ADVISORY BOARD CO
Common Stock |
S - Sale | X | −5 800 | 22 722 | −20,34 | 42,89 | −248 762 | 974 547 |
2012-08-29 |
|
4 | ABCO |
ADVISORY BOARD CO
Common Stock |
M - Exercise | X | 5 200 | 28 522 | 22,30 | 17,41 | 90 532 | 496 568 |
2012-08-22 |
|
4 | ABCO |
ADVISORY BOARD CO
Common Stock Options |
M - Exercise | X | −5 200 | 40 836 | −11,30 | |||
2012-08-22 |
|
4 | ABCO |
ADVISORY BOARD CO
Common Stock |
S - Sale | X | −5 800 | 23 322 | −19,92 | 41,75 | −242 150 | 973 694 |
2012-08-22 |
|
4 | ABCO |
ADVISORY BOARD CO
Common Stock |
M - Exercise | X | 5 200 | 29 122 | 21,74 | 17,41 | 90 532 | 507 014 |
2012-08-15 |
|
4 | ABCO |
ADVISORY BOARD CO
Common Stock Options |
M - Exercise | X | −5 200 | 46 036 | −10,15 | |||
2012-08-15 |
|
4 | ABCO |
ADVISORY BOARD CO
Common Stock |
S - Sale | X | −5 800 | 23 922 | −19,51 | 42,22 | −244 876 | 1 009 987 |
2012-08-15 |
|
4 | ABCO |
ADVISORY BOARD CO
Common Stock |
M - Exercise | X | 5 200 | 29 722 | 21,21 | 17,41 | 90 532 | 517 460 |
2012-08-08 |
|
4 | ABCO |
ADVISORY BOARD CO
Common Stock Options |
M - Exercise | X | −5 200 | 51 236 | −9,21 | |||
2012-08-08 |
|
4 | ABCO |
ADVISORY BOARD CO
Common Stock |
S - Sale | X | −5 800 | 24 522 | −19,13 | 43,39 | −251 662 | 1 064 010 |
2012-08-08 |
|
4 | ABCO |
ADVISORY BOARD CO
Common Stock |
M - Exercise | X | 5 200 | 30 322 | 20,70 | 17,41 | 90 532 | 527 906 |
2012-08-01 |
|
4 | ABCO |
ADVISORY BOARD CO
Common Stock Options |
M - Exercise | X | −5 200 | 56 436 | −8,44 | |||
2012-08-01 |
|
4 | ABCO |
ADVISORY BOARD CO
Common Stock |
S - Sale | X | −5 800 | 25 122 | −18,76 | 45,31 | −262 798 | 1 138 278 |
2012-08-01 |
|
4 | ABCO |
ADVISORY BOARD CO
Common Stock |
M - Exercise | X | 5 200 | 30 922 | 20,22 | 17,41 | 90 532 | 538 352 |
2012-07-25 |
|
4 | ABCO |
ADVISORY BOARD CO
Common Stock Options |
M - Exercise | X | −5 200 | 61 636 | −7,78 | |||
2012-07-25 |
|
4 | ABCO |
ADVISORY BOARD CO
Common Stock |
S - Sale | X | −5 800 | 25 722 | −18,40 | 45,50 | −263 900 | 1 170 351 |
2012-07-25 |
|
4 | ABCO |
ADVISORY BOARD CO
Common Stock |
M - Exercise | X | 5 200 | 31 522 | 19,76 | 17,41 | 90 532 | 548 798 |
2012-07-18 |
|
4 | ABCO |
ADVISORY BOARD CO
Common Stock Options |
M - Exercise | X | −5 200 | 66 836 | −7,22 | |||
2012-07-18 |
|
4 | ABCO |
ADVISORY BOARD CO
Common Stock |
S - Sale | X | −5 800 | 26 322 | −18,06 | 50,23 | −291 334 | 1 322 154 |
2012-07-18 |
|
4 | ABCO |
ADVISORY BOARD CO
Common Stock |
M - Exercise | X | 5 200 | 32 122 | 19,32 | 17,41 | 90 532 | 559 244 |
2012-07-09 |
|
4 | ABCO |
ADVISORY BOARD CO
Common Stock Options |
M - Exercise | X | −5 200 | 72 036 | −6,73 | |||
2012-07-09 |
|
4 | ABCO |
ADVISORY BOARD CO
Common Stock |
S - Sale | X | −1 000 | 26 922 | −3,58 | 50,59 | −50 590 | 1 361 984 |
2012-07-09 |
|
4 | ABCO |
ADVISORY BOARD CO
Common Stock |
S - Sale | X | −4 800 | 27 922 | −14,67 | 49,94 | −239 712 | 1 394 425 |
2012-07-09 |
|
4 | ABCO |
ADVISORY BOARD CO
Common Stock |
M - Exercise | X | 5 200 | 32 722 | 18,89 | 17,41 | 90 532 | 569 690 |
2012-07-03 |
|
4 | ABCO |
ADVISORY BOARD CO
Common Stock Options |
M - Exercise | X | −5 200 | 77 236 | −6,31 | |||
2012-07-03 |
|
4 | ABCO |
ADVISORY BOARD CO
Common Stock |
S - Sale | X | −5 800 | 27 522 | −17,41 | 49,14 | −285 012 | 1 352 431 |
2012-07-03 |
|
4 | ABCO |
ADVISORY BOARD CO
Common Stock |
M - Exercise | X | 5 200 | 33 322 | 18,49 | 17,41 | 90 532 | 580 136 |
2012-06-26 |
|
4 | ABCO |
ADVISORY BOARD CO
Common Stock Options |
M - Exercise | X | −1 820 | 82 436 | −2,16 | |||
2012-06-26 |
|
4 | ABCO |
ADVISORY BOARD CO
Common Stock |
S - Sale | X | −10 800 | 28 122 | −27,75 | 47,72 | −515 376 | 1 341 982 |
2012-06-26 |
|
4 | ABCO |
ADVISORY BOARD CO
Common Stock |
M - Exercise | X | 1 820 | 38 922 | 4,91 | 17,41 | 31 686 | 677 632 |
2012-06-26 |
|
4 | ABCO |
ADVISORY BOARD CO
Common Stock |
M - Exercise | X | 8 380 | 37 102 | 29,18 | 16,20 | 135 756 | 601 052 |
2012-06-22 |
|
4 | ABCO |
ADVISORY BOARD CO
Common Stock Options |
M - Exercise | X | −20 000 | 3 828 | −83,93 | |||
2012-06-22 |
|
4 | ABCO |
ADVISORY BOARD CO
Common Stock |
S - Sale | X | −1 000 | 28 722 | −3,36 | 50,41 | −50 410 | 1 447 876 |
2012-06-22 |
|
4 | ABCO |
ADVISORY BOARD CO
Common Stock |
S - Sale | X | −21 400 | 29 722 | −41,86 | 49,55 | −1 060 370 | 1 472 725 |
2012-06-22 |
|
4 | ABCO |
ADVISORY BOARD CO
Common Stock |
M - Exercise | X | 20 000 | 51 122 | 64,26 | 16,20 | 324 000 | 828 176 |
2012-05-23 |
|
4 | ABCO |
ADVISORY BOARD CO
Common Stock Options |
M - Exercise | X | −2 500 | 11 914 | −17,34 | |||
2012-05-23 |
|
4 | ABCO |
ADVISORY BOARD CO
Common Stock |
S - Sale | X | −2 800 | 15 561 | −15,25 | 95,51 | −267 428 | 1 486 231 |
2012-05-23 |
|
4 | ABCO |
ADVISORY BOARD CO
Common Stock |
M - Exercise | X | 2 500 | 18 361 | 15,76 | 32,40 | 81 000 | 594 896 |
2012-05-17 |
|
4 | ABCO |
ADVISORY BOARD CO
Common Stock |
S - Sale | X | −2 482 | 15 861 | −13,53 | 94,12 | −233 606 | 1 492 837 |
2012-05-16 |
|
4 | ABCO |
ADVISORY BOARD CO
Common Stock Options |
M - Exercise | −10 000 | 42 128 | −19,18 | ||||
2012-05-16 |
|
4 | ABCO |
ADVISORY BOARD CO
Common Stock |
S - Sale | −910 | 18 343 | −4,73 | 95,07 | −86 514 | 1 743 869 | |
2012-05-16 |
|
4 | ABCO |
ADVISORY BOARD CO
Common Stock |
S - Sale | −19 090 | 19 253 | −49,79 | 94,28 | −1 799 805 | 1 815 173 | |
2012-05-16 |
|
4 | ABCO |
ADVISORY BOARD CO
Common Stock |
M - Exercise | 10 000 | 38 343 | 35,28 | 34,81 | 348 100 | 1 334 720 | |
2012-05-16 |
|
4 | ABCO |
ADVISORY BOARD CO
Common Stock Options |
M - Exercise | −20 000 | 52 128 | −27,73 | ||||
2012-05-16 |
|
4 | ABCO |
ADVISORY BOARD CO
Restricted Stock Units |
M - Exercise | −2 482 | 2 162 | −53,45 | ||||
2012-05-16 |
|
4 | ABCO |
ADVISORY BOARD CO
Common Stock |
M - Exercise | 2 482 | 28 343 | 9,60 | ||||
2012-05-16 |
|
4 | ABCO |
ADVISORY BOARD CO
Common Stock |
S - Sale | −20 000 | 25 861 | −43,61 | 93,93 | −1 878 600 | 2 429 124 | |
2012-05-16 |
|
4 | ABCO |
ADVISORY BOARD CO
Common Stock |
M - Exercise | 20 000 | 45 861 | 77,34 | 34,81 | 696 200 | 1 596 421 | |
2012-05-16 |
|
4 | ABCO |
ADVISORY BOARD CO
Common Stock Options |
M - Exercise | −10 000 | 72 128 | −12,18 | ||||
2012-05-16 |
|
4 | ABCO |
ADVISORY BOARD CO
Common Stock Options |
M - Exercise | X | −2 500 | 14 414 | −14,78 | |||
2012-05-16 |
|
4 | ABCO |
ADVISORY BOARD CO
Common Stock |
S - Sale | −10 000 | 25 861 | −27,89 | 93,22 | −932 200 | 2 410 762 | |
2012-05-16 |
|
4 | ABCO |
ADVISORY BOARD CO
Common Stock |
M - Exercise | 10 000 | 35 861 | 38,67 | 34,81 | 348 100 | 1 248 321 | |
2012-05-16 |
|
4 | ABCO |
ADVISORY BOARD CO
Common Stock |
S - Sale | X | −2 800 | 25 861 | −9,77 | 93,45 | −261 660 | 2 416 710 |
2012-05-16 |
|
4 | ABCO |
ADVISORY BOARD CO
Common Stock |
M - Exercise | X | 2 500 | 28 661 | 9,56 | 32,40 | 81 000 | 928 616 |
2012-05-09 |
|
4 | ABCO |
ADVISORY BOARD CO
Common Stock Options |
M - Exercise | X | −2 500 | 16 914 | −12,88 | |||
2012-05-09 |
|
4 | ABCO |
ADVISORY BOARD CO
Common Stock |
S - Sale | X | −2 800 | 26 161 | −9,67 | 91,68 | −256 704 | 2 398 440 |
2012-05-09 |
|
4 | ABCO |
ADVISORY BOARD CO
Common Stock |
M - Exercise | X | 2 500 | 28 961 | 9,45 | 32,40 | 81 000 | 938 336 |
2012-05-01 |
|
4 | ABCO |
ADVISORY BOARD CO
Common Stock |
S - Sale | X | −3 250 | 26 461 | −10,94 | 90,42 | −293 865 | 2 392 604 |
2012-05-01 |
|
4 | ABCO |
ADVISORY BOARD CO
Common Stock Options |
M - Exercise | X | −2 500 | 19 414 | −11,41 | |||
2012-05-01 |
|
4 | ABCO |
ADVISORY BOARD CO
Common Stock |
S - Sale | X | −2 800 | 29 711 | −8,61 | 91,00 | −254 800 | 2 703 701 |
2012-05-01 |
|
4 | ABCO |
ADVISORY BOARD CO
Common Stock |
M - Exercise | X | 2 500 | 32 511 | 8,33 | 32,40 | 81 000 | 1 053 356 |
2012-05-01 |
|
4 | ABCO |
ADVISORY BOARD CO
Restricted Stock Units |
M - Exercise | −3 250 | 6 500 | −33,33 | ||||
2012-05-01 |
|
4 | ABCO |
ADVISORY BOARD CO
Common Stock |
M - Exercise | 3 250 | 30 011 | 12,14 | ||||
2012-04-24 |
|
4 | ABCO |
ADVISORY BOARD CO
Common Stock Options |
M - Exercise | X | −2 500 | 21 914 | −10,24 | |||
2012-04-24 |
|
4 | ABCO |
ADVISORY BOARD CO
Common Stock |
S - Sale | X | −2 800 | 26 761 | −9,47 | 88,10 | −246 680 | 2 357 644 |
2012-04-24 |
|
4 | ABCO |
ADVISORY BOARD CO
Common Stock |
M - Exercise | X | 2 500 | 29 561 | 9,24 | 32,40 | 81 000 | 957 776 |
2012-04-19 |
|
4 | ABCO |
ADVISORY BOARD CO
Restricted Stock Units |
A - Award | 2 168 | 2 168 | |||||
2012-04-18 |
|
4 | ABCO |
ADVISORY BOARD CO
Common Stock Options |
M - Exercise | X | −2 500 | 24 414 | −9,29 | |||
2012-04-18 |
|
4 | ABCO |
ADVISORY BOARD CO
Common Stock |
S - Sale | X | −2 800 | 27 061 | −9,38 | 85,23 | −238 644 | 2 306 409 |
2012-04-18 |
|
4 | ABCO |
ADVISORY BOARD CO
Common Stock |
M - Exercise | X | 2 500 | 29 861 | 9,14 | 32,40 | 81 000 | 967 496 |
2012-04-10 |
|
4 | ABCO |
ADVISORY BOARD CO
Common Stock Options |
M - Exercise | X | −5 000 | 26 914 | −15,67 | |||
2012-04-10 |
|
4 | ABCO |
ADVISORY BOARD CO
Common Stock |
S - Sale | X | −8 100 | 27 361 | −22,84 | 83,56 | −676 836 | 2 286 285 |
2012-04-10 |
|
4 | ABCO |
ADVISORY BOARD CO
Common Stock |
M - Exercise | X | 5 000 | 35 461 | 16,41 | 32,40 | 162 000 | 1 148 936 |
2012-04-04 |
|
4 | ABCO |
ADVISORY BOARD CO
Common Stock Options |
M - Exercise | X | −5 000 | 31 914 | −13,54 | |||
2012-04-04 |
|
4 | ABCO |
ADVISORY BOARD CO
Common Stock |
S - Sale | X | −8 100 | 30 461 | −21,01 | 87,79 | −711 099 | 2 674 171 |
2012-04-04 |
|
4 | ABCO |
ADVISORY BOARD CO
Common Stock |
M - Exercise | X | 5 000 | 38 561 | 14,90 | 32,40 | 162 000 | 1 249 376 |
2012-03-27 |
|
4 | ABCO |
ADVISORY BOARD CO
Common Stock Options |
M - Exercise | X | −5 000 | 36 914 | −11,93 | |||
2012-03-27 |
|
4 | ABCO |
ADVISORY BOARD CO
Common Stock |
S - Sale | X | −8 100 | 33 561 | −19,44 | 86,55 | −701 055 | 2 904 705 |
2012-03-27 |
|
4 | ABCO |
ADVISORY BOARD CO
Common Stock |
M - Exercise | X | 5 000 | 41 661 | 13,64 | 32,40 | 162 000 | 1 349 816 |
2012-03-21 |
|
4 | ABCO |
ADVISORY BOARD CO
Common Stock Options |
M - Exercise | X | −5 000 | 41 914 | −10,66 | |||
2012-03-21 |
|
4 | ABCO |
ADVISORY BOARD CO
Common Stock |
S - Sale | X | −2 594 | 36 661 | −6,61 | 86,89 | −225 393 | 3 185 474 |
2012-03-21 |
|
4 | ABCO |
ADVISORY BOARD CO
Common Stock |
S - Sale | X | −5 506 | 39 255 | −12,30 | 86,14 | −474 287 | 3 381 426 |
2012-03-21 |
|
4 | ABCO |
ADVISORY BOARD CO
Common Stock |
M - Exercise | X | 5 000 | 44 761 | 12,58 | 32,40 | 162 000 | 1 450 256 |
2012-02-28 |
|
4 | ABCO |
ADVISORY BOARD CO
Common Stock |
S - Sale | X | −6 100 | 39 761 | −13,30 | 78,07 | −476 227 | 3 104 141 |
2012-02-28 |
|
4 | ABCO |
ADVISORY BOARD CO
Common Stock |
S - Sale | X | −5 150 | 45 861 | −10,10 | 77,48 | −399 022 | 3 553 310 |
2012-02-28 |
|
4 | ABCO |
ADVISORY BOARD CO
Common Stock |
M - Exercise | X | 11 250 | 51 011 | 28,29 | 39,45 | 443 812 | 2 012 384 |
2012-02-24 |
|
4/A | ABCO |
ADVISORY BOARD CO
Restricted Stock Units |
A - Award | 4 644 | 4 644 | |||||
2012-02-14 |
|
4 | ABCO |
ADVISORY BOARD CO
Common Stock Options |
M - Exercise | X | −11 250 | 11 250 | −50,00 | |||
2012-02-14 |
|
4 | ABCO |
ADVISORY BOARD CO
Common Stock |
S - Sale | X | −11 250 | 39 761 | −22,05 | 72,73 | −818 212 | 2 891 818 |
2012-02-14 |
|
4 | ABCO |
ADVISORY BOARD CO
Common Stock |
M - Exercise | X | 11 250 | 51 011 | 28,29 | 39,45 | 443 812 | 2 012 384 |
2012-01-27 |
|
4 | ABCO |
ADVISORY BOARD CO
Common Stock Options |
M - Exercise | X | −11 250 | 22 500 | −33,33 | |||
2012-01-27 |
|
4 | ABCO |
ADVISORY BOARD CO
Common Stock |
S - Sale | X | −11 250 | 39 761 | −22,05 | 79,05 | −889 312 | 3 143 107 |
2012-01-27 |
|
4 | ABCO |
ADVISORY BOARD CO
Common Stock |
M - Exercise | X | 11 250 | 51 011 | 28,29 | 39,45 | 443 812 | 2 012 384 |
2012-01-12 |
|
4 | ABCO |
ADVISORY BOARD CO
Common Stock Options |
M - Exercise | X | −11 250 | 33 750 | −25,00 | |||
2012-01-12 |
|
4 | ABCO |
ADVISORY BOARD CO
Common Stock |
S - Sale | X | −11 250 | 39 761 | −22,05 | 73,99 | −832 388 | 2 941 916 |
2012-01-12 |
|
4 | ABCO |
ADVISORY BOARD CO
Common Stock |
M - Exercise | X | 11 250 | 51 011 | 28,29 | 39,45 | 443 812 | 2 012 384 |
2009-04-02 |
|
4 | ABCO |
ADVISORY BOARD CO
Restricted Stock Units |
M - Exercise | −8 043 | 8 043 | −50,00 | ||||
2009-04-02 |
|
4 | ABCO |
ADVISORY BOARD CO
Common Stock |
M - Exercise | 8 043 | 8 043 |